 Home > Active Ingredient News > Diagnostic Test > Xinrui α-Radiation Cancer Therapy Receives FDA Breakthrough Medical Device Certification

Xinrui α-Radiation Cancer Therapy Receives FDA Breakthrough Medical Device Certification

 Last Update: 2021-06-20
 Source: Internet
 Author: User

Tags

alpha quartz

medical device manufacturers

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, Alpha Tau Medical announced that its alpha-radiation cancer therapy Alpha DaRT has obtained the Breakthrough Device Designation granted by the US FDA, which is suitable for the treatment of skin and oral scaly without standard treatments.

Breakthrough medical devices are a category designed by the US FDA to accelerate the review process and promote the development of clinical trials of devices for the treatment of life-threatening diseases

Note: The original text has been deleted

Reference materials:

[1] Alpha Tau Receives Breakthrough Device Designation from the FDA for Alpha DaRT™.

[1] Alpha Tau Receives Breakthrough Device Designation from the FDA for Alpha DaRT™.
Retrieved 2021-06-09, from https:// -from-the-fda-for-alpha-dart-301308178.
html

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.